AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $5,000 | -28.6% | 788 | -54.7% | 0.00% | – |
Q3 2019 | $7,000 | -30.0% | 1,739 | -14.9% | 0.00% | – |
Q2 2019 | $10,000 | 0.0% | 2,043 | +64.0% | 0.00% | – |
Q1 2019 | $10,000 | +42.9% | 1,246 | -4.7% | 0.00% | – |
Q4 2018 | $7,000 | +600.0% | 1,307 | +2115.3% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q1 2017 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 59 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 59 | 0.0% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 59 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | -50.0% | 59 | -53.2% | 0.00% | – |
Q4 2015 | $2,000 | – | 126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |